Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Thursday, November 13, 2025 at 11.00 ...
e
SUPRIYA LIFESCIENCE LTD.
.. Creating true va lues that bind global lzealtl,
National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA
November 09, 2025
To,
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434
Dear Sir/Madam,
Subject: Intimation of Earnings Call for Unaudited Financial Results for the quarter and Half year ended September 30, 2025.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Thursday, November 13, 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2025.
The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith.
The investor presentation shall be shared with the Exchanges separately.
Kindly take the information on record.
Thanking you,
For Supriya Lifescience Limited
Prachi Sathe Company Secretary & Compliance Officer
Corporate office
: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX Tel: +91 22 40332727 / 66942507
CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory
: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com
GOVT. RECOGNISED EXPORT HOUSE
Supriya Lifescience Ltd
cordially invites you to their Earnings Call to discuss operational and financial performance
for Q2 FY26
Thursday, 13th November 2025 at 11:00 AM, IST
Diamond Pass Registration Link
Management Representative:
• Dr. Satish Wagh – Executive Chairman & WTD
• Dr. Saloni Wagh – Managing Director
• Mr. Krishna Raghunathan - Chief Financial Officer
Primary Number
Secondary Number
Access Numbers
+91 22 6280 1107
+91 22 7115 8008
Hongkong: 800 964 448
Singapore: 800 101 2045
USA: 1866 746 2133
UK: 0808 101 1573
EY IR - Runjhun Jain - Runjhun.Jain1@in.ey.com / Sneha Salian - Sneha2.Salian@in.ey.com